OHF international hyperoxaluria workshop

Ended Project Grant Awarded Last action

Award ID
R13DK122822
Recipient
Awarding agency
Obligated
-$2,000

Award facts

Assistance listing
93.350 National Center for Advancing Translational Sciences
Completion date
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Place of performance
New York, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$3,500
Amendment -$3,500
Amendment OHF international hyperoxaluria workshop - primary hyperoxaluria is a rare genetic disease that often results in kidney failure and premature death. IT often… -$3,500
Amendment $3,500
Original award $5,000

Quick answers

Who received award R13DK122822?

R13DK122822 was awarded to The Oxalosis & Hyperoxaluria Foundation by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on June 5, 2019.

How much is award R13DK122822 worth?

Obligations on R13DK122822 net to -$2,000: more has been deobligated than obligated.

Which agency awarded R13DK122822?

National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) awarded R13DK122822, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award